Loading...
Leucine-enriched whey protein supplementation, resistance-based exercise, and cardiometabolic health in older adults: a randomized controlled trial.
Kirk, Ben Mooney, Kate Vogrin, Sara Jackson, Matthew Duque, Gustavo Khaiyat, Omid
Kirk, Ben
Mooney, Kate
Vogrin, Sara
Jackson, Matthew
Duque, Gustavo
Khaiyat, Omid
Editors
Other contributors
Affiliation
Epub Date
Issue Date
2021-09-14
Submitted date
Subjects
Alternative
Abstract
Background Increasing protein intake (above the Recommended Dietary Amount) alone or with resistance-based exercise is suggested to improve cardiometabolic health; however, randomized controlled trials (RCTs) are needed to confirm this. Methods The Liverpool Hope University-Sarcopenia Aging Trial (LHU-SAT) was a 16 week RCT (ClinicalTrials.gov Identifier: NCT02912130) of 100 community-dwelling older adults [mean age: 68.73 ± 5.80 years, body mass index: 27.06 ± 5.18 kg/m2 (52% women)] who were randomized to four independent groups [Control (C), Exercise (E), Exercise + Protein (EP), Protein (P)]. E and EP completed supervised and progressive resistance-based exercise (resistance exercise: two times per week, functional circuit exercise: once per week), while EP and P were supplemented with a leucine-enriched whey protein drink (three times per day) based on individual body weight (0.50 g/kg/meal, 1.50 g/kg/day). Outcome measures including arterial stiffness (pulse wave velocity), fasting plasma/serum biomarkers [glucose/glycated haemoglobin, total cholesterol, low-density lipoprotein (LDL), high-density lipoprotein, insulin, resistin, leptin, adiponectin, C-reactive protein, tumour necrosis factor-alpha, interleukin-6, cystatin-C, & ferritin], insulin resistance (HOMA-IR), and kidney function (eGFR) were measured before and after intervention. Results Total protein intake (habitual diet plus supplementation) increased to 1.55 ± 0.69 g/kg/day in EP and to 1.93 ± 0.72 g/kg/day in P, and remained significantly lower (P < 0.001) in unsupplemented groups (E: 1.08 ± 0.33 g/kg/day, C: 1.00 ± 0.26 g/kg/day). At 16 weeks, there was a group-by-time interaction whereby absolute changes in LDL-cholesterol were lower in EP [mean difference: −0.79 mmol/L, 95% confidence interval (CI): −1.29, −0.28, P = 0.002] and P (mean difference: −0.76 mmol/L, 95% CI: −1.26, −0.26, P = 0.003) vs. C. Serum insulin also showed group-by-time interactions at 16 weeks whereby fold changes were lower in EP (mean difference: −0.40, 95% CI: −0.65, −0.16, P = 0.001) and P (mean difference: −0.32, 95% CI: −0.56, −0.08, P = 0.009) vs. C, and fold changes in HOMA-IR improved in EP (mean difference: −0.37, 95% CI: −0.64, −0.10, P = 0.007) and P (mean difference: −0.27, 95% CI: −0.53, −0.00, P = 0.048) vs. C. Serum resistin declined in P only (group-by-time interaction at 16 weeks: P = 0.009). No other interactions were observed in outcome measures (P > 0.05), and kidney function (eGFR) remained unaltered. Conclusions Sixteen weeks of leucine-enriched whey protein supplementation alone and combined with resistance-based exercise improved cardiometabolic health markers in older adults.
Citation
Kirk, B., Mooney, K., Vogrin, S., Jackson, M., Duque, G., et al. (2021) Leucine-enriched whey protein supplementation, resistance-based exercise, and cardiometabolic health in older adults: a randomized controlled trial, Journal of Cachexia, Sarcopenia and Muscle, 12 (6), pp. 2022– 2033, https://doi.org/10.1002/jcsm.12805
Publisher
Research Unit
PubMed ID
34520104 (pubmed)
PubMed Central ID
Embedded videos
Additional Links
Type
Journal article
Language
en
Description
© 2021 The Authors. Published by Wiley. This is an open access article available under a Creative Commons licence.
The published version can be accessed at the following link on the publisher’s website: https://doi.org/10.1002/jcsm.12805
Series/Report no.
ISSN
2190-5991
EISSN
2190-6009
ISBN
ISMN
Gov't Doc #
Sponsors
This work was supported by internal doctoral research scholarships (awarded to B.K. and K.M. during 2016–2019) from Liverpool Hope University who purchased the protein supplements directly from the manufacture (MyProtein, UK) at retail price with no discount applied. No external funding was received for this study.
Rights
Licence for published version: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International